EIS

SS&C Announces Enhancements for Eze Investment Suite and Eze Eclipse

Thursday, September 16, 2021 - 2:00pm

WINDSOR, Conn., Sept. 16, 2021 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced product enhancements to its SS&C Eze platforms Eze Investment Suite (EIS) and Eze Eclipse .

Key Points: 
  • WINDSOR, Conn., Sept. 16, 2021 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced product enhancements to its SS&C Eze platforms Eze Investment Suite (EIS) and Eze Eclipse .
  • The platform enhancements to fixed income and automated trading reinforce SS&C Eze's leadership in front-to-back investment management workflows for its 1,900 clients.
  • "Eze Investment Suite provides a truly synchronized OEMS with sophisticated, real-time views that give our trading desk actionable insights.
  • SS&C Eze added 121 clients to its flagship Eze Investment Suite in 2021, with the majority deploying the software in the cloud.

GBA Business School Under Edvantage Group Officially Founded, Further Expansion in the Guangdong-Hong Kong-Macao Greater Bay Area

Wednesday, September 15, 2021 - 9:55am

After the lighting ceremony, GBA Business School signed two MOUs with Guangdong-Hong Kong-Macao Bay Area Entrepreneurs Union and Hong Kong Cyperport respectively.

Key Points: 
  • After the lighting ceremony, GBA Business School signed two MOUs with Guangdong-Hong Kong-Macao Bay Area Entrepreneurs Union and Hong Kong Cyperport respectively.
  • GBA Business School has held a series of seminars entitled "New Strategic Thinking for the Greater Bay Area" for the past year, with leaders invited from different sectors in the Greater Bay Area to share their practical experiences and insights.
  • With these, GBA Business School hopes to cultivate more future leaders and talents in different areas for the benefit of the Greater Bay Area.
  • In addition, the Group also operates Greater Bay Area Business School (vocational education institution) in Hong Kong, China.

Coalition of 60 Environmental Groups & Community Leaders Demand FDA Ban & Reclassify Oxybenzone, Octinoxate & Octocrylene in OTC Sunscreen

Monday, September 13, 2021 - 6:35pm

The U.S. Virgin Islands and Hawaii are especially vulnerable to the environmental impact of contaminants on coral reefs and both have laws on the books banning toxic sunscreen.

Key Points: 
  • The U.S. Virgin Islands and Hawaii are especially vulnerable to the environmental impact of contaminants on coral reefs and both have laws on the books banning toxic sunscreen.
  • The petitioners, Harith Wickrema, President of Island Green Living Association and Joe DiNardo, retired scientist and industry toxicologist, are the designated signatories for the coalition.
  • The Citizen Petition was prompted by the chemicals' health risks and the negative impacts to waterways and coastlines.
  • If the FDA doesn't protect the public from unsafe sunscreens, then the FDA has not done its job.

vivo Announces X70 Series Global Launch, Advancing Professional Mobile Photography with ZEISS

Friday, September 10, 2021 - 4:00am

The X70 series consisting of the X70, X70 Pro and X70 Pro+ marks the next chapter in vivo's global imaging partnership with ZEISS and their joint pursuit of creating the ultimate mobile photography experience.

Key Points: 
  • The X70 series consisting of the X70, X70 Pro and X70 Pro+ marks the next chapter in vivo's global imaging partnership with ZEISS and their joint pursuit of creating the ultimate mobile photography experience.
  • Aside from encompassing new portrait photography modes by ZEISS and the latest mobile imaging technology, the vivo X70 series lineup is fitted with next-level specs to provide the optimal user experience.
  • "Once again, vivo is breaking boundaries by delivering exceptional mobile photography advancements jointly developed with ZEISS, a global leader in optics and opto-electronics," said Spark Ni, Senior Vice President and CMO of vivo.
  • With the X70 series, vivo is actively closing the gap between mobile and professional photography by infusing user-oriented innovation with cutting-edge technology."

vivo Announces X70 Series Global Launch, Advancing Professional Mobile Photography with ZEISS

Friday, September 10, 2021 - 4:00am

The X70 series consisting of the X70, X70 Pro and X70 Pro+ marks the next chapter in vivo's global imaging partnership with ZEISS and their joint pursuit of creating the ultimate mobile photography experience.

Key Points: 
  • The X70 series consisting of the X70, X70 Pro and X70 Pro+ marks the next chapter in vivo's global imaging partnership with ZEISS and their joint pursuit of creating the ultimate mobile photography experience.
  • Aside from encompassing new portrait photography modes by ZEISS and the latest mobile imaging technology, the vivo X70 series lineup is fitted with next-level specs to provide the optimal user experience.
  • "Once again, vivo is breaking boundaries by delivering exceptional mobile photography advancements jointly developed with ZEISS, a global leader in optics and opto-electronics," said Spark Ni, Senior Vice President and CMO of vivo.
  • With the X70 series, vivo is actively closing the gap between mobile and professional photography by infusing user-oriented innovation with cutting-edge technology."

Emerald Brand Accredited Sales Group Inks Deal With Tissue Plus Manufacturing

Thursday, September 9, 2021 - 8:00pm

HUNTINGTON, N.Y., Sept. 9, 2021 /PRNewswire-PRWeb/ --Next Generation Solutions, LLC (NGS), an Emerald Brand Accredited sales organization, concluded an agreement for exclusive representation with Tissue Plus, LLC (TP) for manufacturing capacity.

Key Points: 
  • HUNTINGTON, N.Y., Sept. 9, 2021 /PRNewswire-PRWeb/ --Next Generation Solutions, LLC (NGS), an Emerald Brand Accredited sales organization, concluded an agreement for exclusive representation with Tissue Plus, LLC (TP) for manufacturing capacity.
  • NGS, an independent sales and consulting group of Emerald Brand, has signed a multi-year exclusive, representing all capacity out of the Tissue Plus plants in both Maine and Maryland.
  • "This sales and consulting agreement will accelerate the production output that TP has on 12 lines of towel, tissue and napkins.
  • A combined Tissue Plus experience in production, and Emerald Brand's innovative R&D expertise will allow us to continue to maintain the quality our clients expect, while securing capacity for all Emerald Brand "TREE-FREE" paper products on the Eastern seaboard of the USA," states Ralph Bianculli, Sr., CEO of Emerald Brand.

First Mining Announces Birch-Uchi Greenstone Belt Consolidation Around Springpole Gold Project

Thursday, September 9, 2021 - 12:30pm

"First Mining's recent land tenure consolidation in the Birch-Uchi Greenstone Belt is another major development for our Company and the region," stated Dan Wilton, CEO of First Mining.

Key Points: 
  • "First Mining's recent land tenure consolidation in the Birch-Uchi Greenstone Belt is another major development for our Company and the region," stated Dan Wilton, CEO of First Mining.
  • First Mining remains focused on advancing and permitting our flagship Springpole Gold Project which hosts the largest known gold deposit in the district and will be a critical strategic asset if more gold resources are found in the region."
  • The Birch-Uchi Greenstone Belt is one of several greenstone belts in the Uchi Subprovince of theWestern Superior Province of the Canadian Shield.
  • About First Mining Gold Corp.
    First Mining is a Canadian gold developer focused on the development and permitting of the Springpole Gold Projectin northwestern Ontario.

DSS’s Impact BioMedical Successfully Synthesizes First Quantum-Based Compound

Tuesday, September 7, 2021 - 1:00pm

Impact BioMedical, Inc., a wholly owned subsidiary of Document Security Systems (NYSE American: DSS), and GRDG Sciences initiated the research project called Quantum in Summer 2020.

Key Points: 
  • Impact BioMedical, Inc., a wholly owned subsidiary of Document Security Systems (NYSE American: DSS), and GRDG Sciences initiated the research project called Quantum in Summer 2020.
  • Through the Quantum research project, Impact BioMedical and GRDG have taken the first step in creating a new way to make medicine.
  • Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS.
  • Impact BioMedical strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades.

First Mining Files Preliminary Base Shelf Prospectus and Registration Statement

Friday, September 3, 2021 - 9:30pm

VANCOUVER, BC, Sept. 3, 2021 /PRNewswire/ -First Mining Gold Corp. ("First Mining" or the "Company")(TSX: FF) (OTCQX: FFMGF) (FRANKFURT: FMG) announces that it has filed a preliminary short form base shelf prospectus (the "Preliminary Shelf Prospectus") with the securities commissions in each of the provinces of Canada, and a corresponding registration statement on Form F-10 (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") under the U.S./Canada Multijurisdictional Disclosure System.

Key Points: 
  • VANCOUVER, BC, Sept. 3, 2021 /PRNewswire/ -First Mining Gold Corp. ("First Mining" or the "Company")(TSX: FF) (OTCQX: FFMGF) (FRANKFURT: FMG) announces that it has filed a preliminary short form base shelf prospectus (the "Preliminary Shelf Prospectus") with the securities commissions in each of the provinces of Canada, and a corresponding registration statement on Form F-10 (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") under the U.S./Canada Multijurisdictional Disclosure System.
  • First Mining has filed this Preliminary Shelf Prospectus and the Registration Statement to provide the Company with greater financial flexibility going forward but has not entered into any agreements or arrangements to authorize or offer any Securities (as defined below) at this time.
  • The Registration Statement filed today with the SEC has not yet become effective.
  • No Securities may be sold, nor may offers to buy be accepted, prior to the time the Preliminary Shelf Prospectus and Registration Statement become effective.

DSS’s Impact BioMedical Reports Positive Test Results for its 3FDB “DEET Booster” Technology

Monday, August 23, 2021 - 2:00pm

These results suggest that 3FDB can boost the effectiveness of mosquito repellants, specifically DEET.

Key Points: 
  • These results suggest that 3FDB can boost the effectiveness of mosquito repellants, specifically DEET.
  • The first test examined 3FDB / DEET concentrations (1% 3FDB with 0.5% DEET) that could be suitable for use in fragrances, shampoos, soaps, and detergents.
  • After three hours, the 3FDB / DEET mixture had a repellency rate of 98%, compared to 85% for DEET alone.
  • Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS and a unique technology source, developer, and business partner in addressing unmet needs in human healthcare and wellness.